MAST CELL ACTIVATION SYNDROME (MCAS)

The Immune Over-Reaction Hiding Behind Dozens of Different Diagnoses.

Mast Cell Activation Syndrome — the chronic, pathological over-activation of mast cells leading to excessive mediator release — is estimated to affect up to 17% of the population yet remains almost entirely unknown to NHS practitioners outside specialist allergy services. Mast cells — distributed in every tissue, particularly near blood vessels, nerves, and mucosal surfaces — are the immune system's primary sensors of environmental threat, releasing histamine, tryptase, prostaglandins, leukotrienes, and cytokines in response to triggers. In MCAS, this release becomes dysregulated: triggered by foods, chemicals, temperature changes, stress, infections, hormonal fluctuations, and physical stimuli. The resulting symptom constellation — spanning every organ system — produces presentations that cycle through numerous diagnostic labels (IBS, fibromyalgia, dysautonomia, chronic fatigue, interstitial cystitis, eczema) without the unifying diagnosis ever being made.